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Constitutively activated NF-κB occurs in many inflammatory and tumor tissues. Does it interfere with anti-inflammatory or anti-tumor signaling
pathway? Here, we report that NF-κB p65 subunit repressed the Nrf2-antioxidant response element (ARE) pathway at transcriptional level. In the
cells where NF-κB and Nrf2 were simultaneously activated, p65 unidirectionally antagonized the transcriptional activity of Nrf2. In the p65-
overexpressing cells, the ARE-dependent expression of heme oxygenase-1 was strongly suppressed. However, p65 inhibited the ARE-driven gene
transcription in away that was independent of its own transcriptional activity. Twomechanismswere found to coordinate the p65-mediated repression
of ARE: (1) p65 selectively deprives CREB binding protein (CBP) from Nrf2 by competitive interaction with the CH1-KIX domain of CBP, which
results in inactivation of Nrf2. The inactivation depends on PKA catalytic subunit-mediated phosphorylation of p65 at S276. (2) p65 promotes
recruitment of histone deacetylase 3 (HDAC3), the corepressor, to ARE by facilitating the interaction of HDAC3with either CBP orMafK, leading to
local histone hypoacetylation. This investigation revealed the participation of NF-κB p65 in the negative regulation of Nrf2-ARE signaling, and
might provide a new insight into a possible role of NF-κB in suppressing the expression of anti-inflammatory or anti-tumor genes.
© 2008 Elsevier B.V. All rights reserved.Keywords: NF-κB; Nrf2; ARE; MafK; CBP; HDAC; Transrepression1. Introduction
NF-κB is a widely expressed, pleiotropic transcription factor.
Aberrant NF-κB activity is implicated in diverse pathological
processes including infection, inflammation and cancer [1]. NF-
κB is composed of homo- and heterodimeric complexes of
members of the Rel family of proteins, consisting of p65 (RelA),
c-Rel, RelB, p50, and p52. The best-studied and most abundant
component of these complexes is the p65/p50 heterodimer. This
heterodimer is normally maintained in the cytoplasm by inhib-
itor molecule IκB. Following a variety of extracellular stimuli
such as pro-inflammatory stimuli, genotoxic and oxidative
stress, the IκB kinase (IKK) signalosome is activated. Then, the
activated IKK phosphorylates and degrades IκB. As a con-⁎ Corresponding author. Center for System Biology, Institute of Biophysics,
Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing,
100101, P.R. China. Tel: +86 10 64888575.
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0167-4889/$ - see front matter © 2008 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2008.01.002sequence, the p65/p50 complex is liberated, moves to nucleus,
binds to the promoter region of the target genes, and induces
their expression [2]. In nucleus, p65 concerts gene transcription
by recruiting either coactivators, such as CREB binding protein
(CBP) [3,4], or corepressors, such as histone deacetylases
(HDACs), to target gene [5–8]. It has two opposing effects on
gene transcription. Upon activation, p65 drives expression of its
target genes, but also suppresses transcription of others. Of note,
the transcription mediated by glucocorticoid receptor (GR),
PPARγ , MEF2, or p53 has been reported to be repressed by
activated p65 [7,9–11]. However, whether NF-κB p65 subunit
suppresses the antioxidant responsive element (ARE)-driven
gene transcription is unknown.
Nrf2 is amember of theCNC-basic leucine zipper (CNC-bZIP)
family of transcription factors, which coordinately regulates the
constitutive and inducible expression of antioxidant and phase 2
detoxification enzymes, such as heme oxygenase-1 (HO-1) and
NAD(P)H:quinone oxidoreductase 1 (NQO1), via a cis-acting
DNA element called ARE [12,13]. A bulk of evidence from
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pensable for body defense against oxidants, carcinogens, and
inflammatory insults [14–16]. Thus, Nrf2-ARE pathway has been
proposed to be a promising target for the anti-inflammation and
cancer prevention [17,18]. Nrf2 is normally maintained in
cytoplasm by its cytosolic repressor protein Keap1 [19,20].
Keap1 negatively regulates Nrf2 by both enhancing its rate of
proteasomal degradation and altering its subcellular distribution
under oxidative, inflammatory or toxic stress [21]. As a result,
Nrf2 translocates to nucleus, forms heterodimer with small Maf
protein (MafK,MafGorMafF) and binds toARE sequences in the
promoter region of the genes which encodes antioxidant and
detoxification enzymes [22]. Although it was recently reported
that some nuclear proteins, such as Bach1 [23] and estrogen
receptor [24], antagonizeNrf2 activity, there has been no report on
the interference of NF-κB with Nrf2-ARE signaling.
Since a variety of anti-inflammatory or anti-carcinogenetic
phytochemicals suppresses NF-κB signaling and activates Nrf2-
ARE pathway as well [25–27], one may ask if the suppression of
NF-κB signaling and the activation of Nrf2-ARE pathway are
totally independent or may crosstalk with each other in some
way. On the other hand, as NF-κB andNrf2 plays contrary role in
the pathological processes of inflammation and cancer, and a
large number of pathological stimuli, such as cigarette smoke,
lipopolysaccharide (LPS), flow shear stresses, oxidized low-
density lipoprotein, and reactive oxygen species, activates both
NF-κB signaling and Nrf2-ARE pathway [28–35], one may also
ask if there is any regulatory mechanism to integrate these two
functionally opposing pathways and finally determine the
transcriptional outputs? Based on above considerations, we
postulate a crosstalk between NF-κB and Nrf2 signaling. In this
investigation, NF-κB p65 subunit was found to unidirectionally
antagonize ARE-mediated gene transcription through two
distinct but interconnected mechanisms.
2. Materials and methods
2.1. Chemicals, antibodies and plasmids
12-O-tetradecanoylphorbol-13-acetate (PMA), tert-butylhydroquinone (t-BHQ),
suforaphane (SFN), cadmium chloride (Cd2+), trichostatin A (TSA), MG132,
antibodies against HA and Flag, and other unspecified reagents were obtained
from Sigma. Antibodies against Gal4-DBD, HO-1, MafK, c-Myc, CBP, HDAC3,
Nrf2, and p65 were purchased from Santa Cruz. Anti-acetylated Lysine antibody
was purchased from Cell Signaling Technology. Anti-acetylated histone H4
antibody was purchased from Upstate. Gal4-MafK serial deletion mutants were
made by subcloning the corresponding rat MafK cDNA fragment into the pBIND
vector (Promega). The following plasmids used in this study were obtained
as gifts: NQO1(ARE)-Luc [36], NQO1(ARE-mut)-Luc, HO-1(ARE)-Luc,
GPX2(ARE)-Luc [34]; pHO-1(E1)-Luc, pHO-1(E1-ARE mut)-Luc [38],
pSilencer3.1-p65 siRNA vector [39], myc-p65, p65(S205A), p65(S276A),
p65(S281A)[40], p65(S536A) [41], p65 truncated mutants [42], V5-MafK
[43], Gal4-Nrf2(TAD, 1–317aa) [44], Nrf2(E82G) [45], RSV-E1A, HA-CBP
[46], GST-CBP(116-738) [47], PKAc(WT), PKAc(K72H) [48], HDAC4/5
[49], pNF-κB-luciferase was obtained from Clontech.
2.2. Cell culture and transfection
HepG2, HEK293, and L929 cells were cultured in DMEM medium
containing 10% fetal calf serum (FCS) at 37 °C in CO2 incubator. Cell
transfection was performed with the FuGENE 6 (Roche) transfection reagent (forHepG2 cells) or JetPei (Polyplus) transfection reagent (for HEK293 and
L929cells). The p65-stably expressed L929 cells were obtained by transfection of
Myc-p65 vector and selection with 300 μg/ml G418. The transient transfection
and luciferase reporter analysis were carried out as previously described [50]. In
brief, cells were transfected with various combinations of a luciferase reporter
plasmid and desired expression vectors (The amounts of each kind of expression
vectors were equal if it is not specified) as well as CMV-β-galactosidase
expression plasmid as internal control. Total DNA quantity was kept constant by
adding proper amount of pcDNA3 or relevant empty vectors. The luciferase
activity normalized against the β-galactosidase activity represents the transcrip-
tional efficiency of the reporter. All transfection throughout this investigation
were performed in triplicate, and each assay was repeated at least three times.
Results are presented as the folds of induction for the respective vectors or
reagents. All data are shown as the mean±SD of three independent experiments.
2.3. RNA interference
The siRNA for p65 and the nonspecific oligonucleotide (mock RNA) are 5′-
GAUCAAUGGCUACACAGGA-3′ [39] and 5′-UUCUCCGAACGUGU-
CACGU-3′ respectively. They were synthesized by GenPharma. HepG2 cells
were transfected with siRNA using Lipofectamine 2000 (Invitrogen), and all
experiments with knockdown of p65 were performed 72 h after transfection. In
reporter assay, siRNA expression vector-based p65 knockdown was employed.
2.4. Reverse transcription (RT)-PCR
Total RNA isolated fromHepG2 cells was reverse-transcribed to cDNAbyRT-
PCR using the following primers:5′-GAGACGGCTTCAAGCTGGTGATG-3′/
5′-GAACTTGGTGGCACTGGCAATG-3′ for HO-1, and 5′-GAAGCATTT-
GCGGTGGACCA-3′/5′-TCCTGTGGCATCCACCAAAC-3′for β-actin.
2.5. GST pull-down, immunoprecipitation, and immunoblotting
The nuclear proteins were isolated with NE-PER Nuclear and Cytoplasmic
Extraction Reagents (Pierce) or according to reference [51]. In GST pull-down
assay, purified GST-CBP(116–738) or GST protein together with glutathione
Sepharose beads (Amersham Pharmacia) was added to 500 μg nuclear extract
isolated from transfected HEK293 cells. After gentle rocking at 4 °C for 4 h,
Sepharose beads were precipitated by centrifugation and washed 3 times with
PBS containing 0.2% NP-40. The proteins were eluted from the beads by adding
SDS loading buffer and subjected to immunoblotting analysis with anti-HA or
anti-Flag antibodies. In immunoprecipitation assays, corresponding agarose
beads-conjugated antibodies were incubated with 500 μg cell lysate in ice-cold
lysis buffer (50 mM Tris–HCl [pH 7.5], 150 mM NaCl, 10 mM NaF, 1% Triton
X-100, 1 mM Na3VO4, 5% glycerol, and the protease inhibitor cocktail). The
lysis buffer used for CBP-HDAC3 interaction is according to reference [52]. The
beads were extensively washed with lysis buffer, and the immunoprecipitates
were analyzed by immunoblotting with proper antibodies. For immunoblot
detection of HO-1 or Nrf2, cells were lysed directly in 2× SDS loading buffer.
The whole-cell extracts (WCL) were sonicated and boiled at 100 °C for 20 min
prior to loading on SDS-polyacrylamide gels. Procedure for immunoblotting has
been described previously [50].
2.6. In vivo acetylation/deacetylation analysis
HEK293 cells were transfected with GAL4-MafK alone or cotransfected
with GAL4-MafK and CBP and/or HDAC expression vectors. 40 h after
transfection, the cells were harvested and lysed in the lysis buffer (20 mM Tris–
HCl [pH 7.5], 150 mM NaCl, 10 mM NaF, 1% Triton X-100, 1 mM Na3VO4,
1mM EDTA, 1 mM EGTA, 5% glycerol, and the protease inhibitor cocktail).
The lysates were then immunoprecipitated with anti-MafK antibody, and the
immunoprecipitates were probed with an anti-pan-Acetyl antibody.
2.7. Determination of HDAC activity in vitro
400 μg nuclear extracts of HepG2 cells were isolated and incubated with
anti-MafK antibody together with Protein A/G PLUS-Agarose beads (Santa
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assay using Colorimetric Detection Histone Deacetylase Assay Kit (Upstate
Biotech.). The absorbance at 405 nm (OD405) of each sample was measured
with a Bio-Rad plate Reader and subtracted the background absorbance of
Protein A/G PLUS-Agarose beads. Results are presented as fold induction of the
net OD450 relative to control. All data are shown as the mean±SD of three
independent measurements.
2.8. DNA affinity pull-down assay
The sense and antisense oligonucleotides for NQO1(ARE) (sense sequence:
5′-CTCAGCCTTCCAAATCGCAGTCACAGTGACTCAGCAGAATC-3′)
were synthesized, labeled with biotin at their 5′ end, and then annealed with each
other to produce biotin-ARE double-stranded oligonucleotide probe. 500 μg of
precleared nuclear extract was incubated with 1 μM biotin-ARE probe and
500 μl streptavidin MagneSphere paramagnetic beads (Promega) in EMSA
binding buffer (10 mM Tris, 50 mM KCl, 1 mM DTT, 2% glycerol and 1 μg
poly(dI/dC), pH7.5) at 4 °C for 2 h, and the beads were then extensively washed
with the binding buffer. The beads-bound proteins were eluted with SDS loading
buffer, and detected by immunoblotting using anti-HA antibody.
2.9. Chromatin immunoprecipitation (ChIP) assay
ChIP assay was performed according to reference with minor modifications
[53]. For assay in Fig. 5, 1×107 HEK293 cells were cotransfected with (UAS)5-
TATA-Luc reporter plasmid (3 μg), Gal4-MafK or Gal4 expression vectors (4 μg),
together with or without 4 μg p65 expression vector. 40 h after transfection, the
ChIP assay was carried out using the ChIP kit (Upstate Biotech) following
manufacture-provided protocol. Briefly, cells were treated with 1% formaldehyde
to cross-link Gal4 or Gal4 fusion protein to the UAS of pG5-Luc DNA. Then, the
cells were harvested, lysed with SDS lysis buffer, and sonicated to shear DNA into
fragments between 200 and 1000 bp. The sheared samples were diluted and pre-
cleared with Salmon Sperm DNA/Protein A agarose at 4°°C for 30 min. The
immunoprecipitation was conducted with anti-Gal4 or anti-CBP antibody,
together with Salmon Sperm DNA/Protein A agarose. The immunoprecipitates
were eluted from beads using elution buffer, and treated with 20 μl of 5 M NaCl
and heated to 65 °C for 4 h to reverse Gal4 orGal4 fusion polypeptide-DNAcross-
link. After treatment with EDTA and proteinase K, DNAwas purified. The target
sequence in (UAS)5-TATA-Luc was amplified by PCR using a primer set of 5′-
GGTACCGAGTTTCTAGACG-3′ and 5′-TTATGTTTTTGGCGTCTTCC-3′.
For Fig. 7, the assay was performed in L929 cells with anti-MafK, anti-
HDAC3, or anti-acetylated histone H4 antibody using the same protocol. The
primer set used to amplify E1 enhancer region of mouse HO-1 promoter are 5′-
TGAAGTTAAAGCCGTTCCGG-3′ and 5′-AGCGGCTGGAATGCTGAGT-3′.
3. Results
3.1. p65 antagonized Nrf2-mediated ARE-dependent gene
expression
As a widely used pro-inflammatory and pro-carcinogenetic
reagent, PMA can induce nuclear translocation of both p65 and
Nrf2 in HepG2 hepatoma cells [54,55]. It was used to stimulate
HepG2 cells and see how these two transcriptional factors are
activated. The immunoblot analysis showed that PMA stimula-
tion markedly enhanced the nuclear level of p65 and promoted
nuclear translocation of Nrf2 within 2 h (Fig. 1A). To evaluate the
transcriptional activities of p65 and Nrf2 when both are
accumulated in nucleus, HepG2 cells were transfected with NF-
κB-Luc or HO-1(ARE)-Luc reporter, and then stimulated by
PMA. It was found that PMA effectively induced NF-κB
transactivation (15-fold of induction), but only slightly activated
ARE-driven gene transcription (1.5-fold) (Fig. 1B). The relative
weak activation of Nrf2may indicate that PMA is not a prototypicactivator of Nrf2. To assess the possibility that activated NF-κB
may antagonize Nrf2-mediated activation of ARE, the ARE
transactivity was examinedwhen NF-κB signaling was enhanced
or blocked. At first, the HO-1(ARE)-Luc reporter and the
expression vector for either of IKKβ, p65 and p50 were
cotransfected into HepG2 cells to see if the cotransfected p65
could affect the PMA-induced expression of the ARE-driven
luciferase. As shown in Fig. 1C, the cotransfected p65 or its
upstream kinase IKKβ, but not p50, substantially repressed
PMA-induced transactivation of ARE, which indicates that the
NF-κB p65 subunit suppresses the ARE transactivity. Then, it
was examined if ARE transactivity was also changed in the cells
having their endogenous p65 knocked down. As Fig. 1D shows,
depletion of the endogenous p65 markedly enhanced the PMA-
induced expression of the HO-1(ARE)-driven reporter. Mean-
while, the effect of the transfected Nrf2 on NF-κB transactivity
was investigated in order to know ifNrf2 also antagonizedNF-κB
transactivity using pNF-κB-luciferase reporter consisting of four
sequential κB consensus sites (GGGAATTTCC) upstream the
herpes simplex virus-TK TATA-like promoter. It was turned out
that overexpression of Nrf2 did not show any interference with
the PMA-induced NF-κB activity (Fig. 1E). These observations
clearly demonstrate that p65 unidirectionally antagonizes Nrf2-
mediated ARE transactivation if they were simultaneously
accumulated in nucleus.
Oxidative and toxic insults usually occur in inflammatory and
tumor tissues where p65 is constitutively accumulated in cell
nuclei [56–60]. In order to establish a connection between
constitutive activation of p65 and the expression of ARE-driven
antioxidant gene, the protein level of HO-1 was examined in the
p65-overexpressing cells in which p65 is mainly localized in
nucleus due to relative deficiency of cytosolic IκB (data not
shown). Cadmium ion (Cd2+), a pro-inflammatory and pro-
carcinogenetic heavy mental ion, was used to induce HO-1
expression [38]. Western blot analysis revealed that the p65
overexpressed either in stable transfected L929 cells or in
transient transfected HEK293 cells substantially inhibited Cd2+-
stimulated HO-1 expression (Fig. 2A). As control, similar
suppression of HO-1 induction was observed in the cells over-
expressing a dominant-negative mutant of Nrf2, DN-Nrf2 (see
lower panel in Fig. 2A). To know whether p65 represses HO-1
expression through interference with Nrf2-ARE pathway, the
reporter, pHO-1(E1)-Luc, containing a E1 enhancer that consists
of three AREs at 5′-terminal of HO-1 gene and mediates Cd2+-
induced activation of HO-1 gene [38], was transfected into
HEK293 cells to see if increased p65 could inhibit the
transactivation of this enhancer. As Fig. 2B shows, cadmium
ions caused 4-fold increase of the E1 enhancer-driven HO-1
minimal promoter-mediated transcription of the luciferase. As
expected, the transcription was completely abrogated by
cotransfection of p65 or DN-Nrf2. To further confirm the
repression of ARE-driven gene expression by p65, more
efficient Nrf2 activators, hemin [61], tert-butylhydroquinone
(tBHQ) [62] and sulforaphane (SFN) [63], were used to
stimulate the cells in which either pHO-1(E1)-Luc or pNQO1
(ARE)-Luc reporter was cotransfected with p65 or DN-Nrf2.
Similar to the stimulation by Cd2+, the hemin-induced (Fig. 2C)
Fig. 1. p65 antagonizes PMA-induced ARE activation. (A) Immunoblot analysis of p65, Nrf2 and histone H1 (control) in the nuclear extracts isolated from the HepG2
cells at indicated time after stimulation with 100 nM PMA. The immunoblot for histone H1 was used to indicate equal loading of the sample in each lane.
(B) Differential response of NF-κB and ARE-driven reporter towards PMA stimulation. HepG2 cells transfected with NF-κB-Luc or ARE-Luc reporter plasmid were
stimulated with 100 nM PMA for 8 h. The luciferase activities were determined and normalized against the β-galactosidase activity. (C) Effects of IKKβ, p65 and p50
on the PMA-induced transcription of the HO-1(ARE)-Luc reporter in HepG2 cells. (D) PMA induced transcription of the HO-1(ARE)-Luc reporter in the HepG2 cells
where the endogenous p65 was knocked down by p65 siRNA. (E) PMA induced transcription of the NF-κB-Luc reporter in the HepG2 cells cotransfected with either
Nrf2 or the corresponding empty vector pEF. In the all experiments shown in C–E, the HepG2 cells were cotransfected with HO-1(ARE)-Luc or NF-κB-Luc reporter
plasmid together with indicated expression vectors (IKKβ, p65, p50, and Nrf2 for 40 h, and p65 siRNA vector for 72 h) and then stimulated with PMA for 8 h. The
cells cotransfected with reporter gene and corresponding empty or mock vector (pcDNA3, pSilencer-mock, pEF) were used as controls. In addition, the whole cell
lysate (WCL) (for C, D, E) were isolated under each transfection condition, and subjected to immunoblot analysis for p65 (for C, D), Flag-IKKβ (for C) or Nrf2 (for E)
expression. They were shown at bottom of each panel respectively.
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(Fig. 2D) was completely repressed by cotransfection of p65 or
the Nrf2 mutant.Fig. 2. p65 inhibits Nrf2-mediated ARE activation. (A) Effect of overexpressed p65
with myc-p65 and the HEK293 cells transiently transfected with myc-p65 or dominan
for 6 h. The whole cell lysates were then immunoblotted for determining cellular cont
1(E1)-Luc and its mutant, pHO-1(E1-AREs mut)-Luc. Lower panel: Effects of p65 a
HO-1(E1) enhancer-driven luciferase gene. HEK293 cells were cotransfected with pH
30 h, then stimulated by cadmium chloride (10 μM) for 6 h. The normalized luciferas
mutant on the hemin-induced transcription of the HO-1(E1) enhancer-driven luciferas
and either p65 or DN-Nrf2 expression vector for 30 h, then stimulated by hemin (10 μ
p65 and the Nrf2 dominant-negative mutant on the tBHQ or SFN-induced transcript
with NQO1(ARE)-Luc reporter plasmid and either p65 or DN-Nrf2 expression vect
normalized luciferase activities were determined. (E) Repression of the Nrf2-medi
luciferase gene by overexpression of p65. HepG2 cells were cotransfected with indica
normalized luciferase activities were determined. (F) Enhancement of the Nrf2-med
luciferase gene by knockdown of endogenous p65. HepG2 cells were cotransfected w
Nrf2 plus mock RNA or Nrf2 plus p65 siRNA vector for 72 h. The normalized lu
transcription of HO-1(E1)-driven luciferase gene via mutating the AREs in the reporte
with various combination of Nrf2 and p65 expression vector into HEK293 cells. 30
Abrogation of the Nrf2-mediated transcription of NQO1(ARE)-driven luciferase gene
(ARE-mut)-Luc was cotransfected with various combination of Nrf2 and p65 expre
activities were determined.To know if the inhibitory effect of p65 onARE is dependent on
the sequence context of ARE, three luciferase reporters driven by
different ARE from HO-1, GPX2, and NQO1 gene or theiron the Cd2+-induced HO-1 protein expression. The L929 cells stably transfected
t-negative mutant of Nrf2, Nrf2(DN-Nrf2), were stimulated with CdCl2 (10 μM)
ents of HO-1. (B) Upper panel: Schematic structure of the reporter plasmid pHO-
nd the Nrf2 dominant-negative mutant on the Cd2+-induced transcription of the
O-1(E1)-Luc reporter plasmid and either p65 or DN-Nrf2 expression vector for
e activities were determined. (C) Effects of p65 and the Nrf2 dominant-negative
e gene. HEK293 cells were cotransfected with pHO-1(E1)-Luc reporter plasmid
M) for 6 h. The normalized luciferase activities were determined. (D) Effects of
ion of the NQO1(ARE)-driven luciferase gene. HepG2 cells were cotransfected
or for 30 h, then stimulated with tBHQ (100 μM) or SFN(25 μM) for 7 h. The
ated transcription of the HO-1(ARE)-, GPX2(ARE)- and NQO1(ARE)-driven
ted reporter plasmid and expression vectors (Nrf2 or Nrf2 plus p65) for 30 h, then
iated transcription of the HO-1(ARE)-, GPX2(ARE)- and NQO1(ARE)-driven
ith indicated reporter plasmid and expression vectors for mock RNA, p65 siRNA,
ciferase activities were then determined. (G) Abrogation of the Nrf2-mediated
r. pHO-1(E1)-Luc and its mutant, pHO-1(E1-AREs mut)-Luc, was cotransfected
h after transfection, the normalized luciferase activities were determined. (H)
via mutating the ARE in the reporter. pNQO1(ARE)-Luc and its mutant pNQO1
ssion vector into HapG2 cells. 30 h after transfection, the normalized luciferase
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in upper panel of Fig. 2B) and NQO1(ARE-mut), were respec-
tively transfected with Nrf2 and/or p65 expression vector into
HepG2 cells. As Fig. 2E shows, all of the three AREs could be
effectively activated by Nrf2, and unanimously suppressed by the
cotransfected p65. However, overexpression of Nrf2 no longer
activated expression of the reporter genes if the AREs or ARE
upstream luciferase gene was mutated (Fig. 2G and H). For
convenience of comparison, the ARE sequences in the studied
reporters were listed in Table 1. Consistently, knockdown of the
endogenous p65 by siRNAenhanced theNrf2-mediated activationof those AREs (Fig. 2F). Similar results were obtained with SH-
SY5Y, HeLa, Eahy.926, and A549 cells (data not shown). Taken
together, all above results demonstrate that either PMA-stimulated
nuclear accumulation of p65 or the ectopic overexpression of p65
effectively blocks the Nrf2-mediated ARE activation.
3.2. Repression of ARE by p65 is independent on transcriptional
induction of NF-κB target genes
The effective repression of the ARE-dependent gene expres-
sion by p65 may suggest a direct interaction of p65 with some
Table 1
Comparison of the ARE sequences in the promoters upstream luciferase gene in various studied reporters with the ARE in mouse NQO1 gene
Enhancer Species ARE sequence in promoter Reference
HO-1(ARE) Human GAACCATGACTCAGCGAAAAC Banning et al. Mol. Cell Biol. 25 (2005) [37]
GPX2(ARE) Human CCAGGATGACTTAGCAAAAAC
NQO1(ARE) Rat TCACAGTGACTCAGCAGAATC Lee et al. Biochem. Biophys. Res. Commun. 280 (2001) [36]
NQO1(ARE-mut) Rat TCACAGTGACTCAatAGAATC
HO-1(E1) Mouse …TGCTGAGTTG…TGCTGTGTCA…TGCTGAGTCA… Alam et al. J. Biol. Chem. 275 (2000) [38]
HO-1 (E1-AREs mut) Mouse …gctTGAGTTG…TGCgtaGatc…TGCgtAGatc…
Mouse NQO1(ARE) Mouse TCACAGTGAGTCGGCAAAATT Nioi et al. Biochem. J. 374 (2003) [13]
Note. The lowercase letters indicate the mutation in ARE. The underlined sequences are the ARE consensus sequences. As the original author indicated, the sequence
of mouse NQO1(ARE) and the first ARE sequence of HO-1(E1) are non-classical.
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immunoprecipitation (CO-IP) and fluorescence resonance
energy transfer (FRET) studies failed to prove any interaction
of p65 with ARE signaling-related proteins such as Keap1,
Nrf2, MafK, and Bach1 (data not shown). Besides that,
interference of p65 with protein stability, subcellular localiza-
tion, and DNA-binding activity of Nrf2 was also not observed
(data not shown).
p65 contains a C-terminal transactivation domain (TAD) and
a N-terminal Rel-homology domain (RHD). To identify the
functional domain(s), which is responsible for p65-mediated
repression of ARE, a series of C-terminal truncated p65 mutants
were transfected respectively with either both HO-1(ARE)-Luc
reporter plasmid and Nrf2 expression vector or NF-κB-Luc
reporter into HepG2 cells. As Fig. 3A shows, except for the
wild-type p65, all of the tested C-terminal TAD-truncated
mutants, p65(1–312), p65(1–420) and p65(1–450), lost their
capacity to repress ARE (upper panel in Fig. 3A). Western
blotting confirmed that all those truncated p65 proteins were
expressed at comparable levels as the wild-type p65 protein
(Fig. 3E). The results may indicate the necessity of the TAD
domain for the transrepression activity of p65.
Since the above TAD-deleted p65 mutants completely lost
their ability to transactivate NF-κB target gene (Fig. 3A), could
be certain products of the NF-κB-targeted genes responsible for
the inhibition of ARE activity? For this reason, three reported
transcription-inactive p65 mutants, p65(S205A), p65(S281A)
and p65(S536A) [40] was used in the same reporter system to
see if they were unable to repress Nrf2-mediated activation of
ARE. It was surprisingly found that all of them had similar
ability as wild type p65 in repressing the Nrf2-mediated
activation of ARE, though they could not activate transcription
of the NF-κB regulatory element (see Fig. 3B). At mRNA level,
it was found that both p65(WT) and p65(S281A) suppressed
Nrf2-induced HO-1 expression to a similar extent (see Fig. 3C).
Therefore, these experiments may reveal that p65 itself but not
any product of the NF-κB-targeted genes would be responsible
for the repression of ARE.
3.3. p65 represses Nrf2 transactivity by deprivation of CBP
from Nrf2
As a common coactivator for Nrf2 and p65, CBP is required
for the transactivity of Nrf2 [4,44]. Therefore, it was studied ifp65 inhibits Nrf2 activity by competitive association with CBP.
First of all, the roles of CBP in maintaining p65 and Nrf2
transactivity were compared. Either Nrf2/ARE-Luc or p65/NF-
κB-Luc was cotransfected with or without adenovirus E1A, a
CBP inhibitory protein [4], into HepG2 cells. Then, the in-
hibitory effects of E1A on the transcriptional activity of Nrf2
and p65 were determined. As Fig. 4A shows, E1A inhibited
transactivity of both p65 and Nrf2 in a dose-dependent manner.
However, the Nrf2-mediated transactivation was more sensitive
to E1A, suggesting that the transactivity of Nrf2 may be more
dependent on CBP.
Since Nrf2 recruits CBP through its N-terminal transactiva-
tion domain (TAD) [44], we examined whether p65 could
deprive CBP from the TAD of Nrf2. HEK293 cells were
transfected with GAL4-Nrf2(TAD) and/or Flag-p65 to see if the
cotransfected p65 could affect the association of the endogen-
ous CBP to GAL4-Nrf2(TAD). As the immunoprecipitation
analysis in Fig. 4C shows, both Gal4-tagged Nrf2 (TAD) and
Flag-tagged p65 were able to associate with the endogenous
CBP when each of them was individually expressed. However,
once Gal4-Nrf2(TAD) and Falg-p65 were coexpressed,
decreased association of CBP with Nrf2(TAD) was observed.
It suggests that the increased nuclear p65 may prevent CBP
from association with Nrf2(TAD) (lane 2 vs. lane 3 in Fig. 4B).
As a positive control, the cotransfected E1A completely abol-
ished the binding of CBP to Nrf2(TAD) (lane 2 vs. lane 4 in
Fig. 4B). In a parallel mammalian one-hybrid experiment, it was
also found that p65 suppressed the Nrf2(TAD)-mediated
transactivation as effectively as E1A.(Fig. 4C).
Domain analysis revealed that the CH1-KIX region on CBP
might be a shared region that interacts with either Nrf2 or p65
[41,64,65]. Therefore, it was examined if competition from p65
for this region could lead to dissociation of CBP from Nrf2.
GST-pull down assay showed that GST-fused CBP(116-738)
fragment, which contains the CH1-KIX region, rather than GST
alone specifically interacted with Nrf2 in the nuclear extract of
the HA-Nrf2-transfected HEK293 cells (Fig. 4D). However,
instead of HA-Nrf2, the Flag-p65 tightly associated with GST-
CBP(116–738) when Flag-p65 and HA-Nrf2 were cotrans-
fected in cells. It suggests that p65 deprives CBP from Nrf2
though competition for the CH1-KIX domain of CBP.
Since interaction between p65 and CBP largely depends on
the phosphorylation of p65 at S276 that is catalyzed by the
catalytic subunit of PKAc [65] it is expected that PKAc should
Fig. 3. The effects of p65 mutants on ARE activation. HepG2 cells were cotransfected with ARE-Luc reporter plasmid and Nrf2 expression vector (upper panels in A
and B) or NF-κB-Luc reporter plasmid (lower panels in A and B) together with or without the expression vectors of various p65 mutants for 30 h, and then the
normalized luciferase activities were determined. Panel (A) and (B) show the effect of the C-terminal truncated, and phosphorylation-deficient p65 mutant on the Nrf2-
mediated ARE activation and NF-κB-driven reporter transcription respectively. Panel (C), RT-PCR analysis of HO-1 mRNA level in HepG2 cells transiently
transfected with Nrf2, together with or without p65(WT) or p65(S281A). (D) Schematic representation of the p65 mutants constructs used in above experiments. Their
abilities in inducing transcription of NF-κB-driven reporter and inhibiting ARE activation are indicated as “+” (significant), “−” (not significant) or “+ +” (very
significant). WT represents wild type p65; 1–450, 1–420 and 1–312 represent the C-terminal truncated p65 mutants; S205A, S281A and S536A represent
phosphorylation-deficient p65 mutants. (E) Expression of p65 C-terminal truncated mutants in HepG2 cells. HepG2 cells were transfected with indicated expression
plasmids. 48 h latter, cells were lysed and subjected to immunoblotting with anti-p65 (N-terminal) antibody. Shorter exposure displays the comparable expression
levels of wild-type p65 and p65 mutants. Longer exposure enabled visualization of the endogenous p65.
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CBP association. Utilizing HO-1(ARE)-Luc as reporter, it was
actually observed that overexpression of PKAc significantly
inhibited Nrf2-mediated ARE activation, whereas its kinase-
dead mutant (PKAc-K72H) had no inhibitory effect (Fig. 4E). It
was also found that PKAc even aggravated the inhibitory effect
of p65 on the ARE activation (column 3 vs. 5 in Fig. 4E).
Nevertheless, the phosphorylation-deficient p65 mutant p65
(S276A) that cannot bind to CBP [65], showed no inhibitory
effect on Nrf2(TAD) (Fig. 4F). Consistently, the wild-type p65-mediated inhibition of Nrf2(TAD) was reversed by over-
expression of CBP (column 3 vs. 4 in Fig. 4G). These results
clearly demonstrate that phosphorylation of p65 at Ser276 is
critical for the interaction of p65 with CBP and subsequent p65-
mediated repression of Nrf2 transactivation.
Small Maf protein, the DNA-binding partner of Nrf2, has
been reported to be essential for Nrf2-mediated activation of
ARE [22] and to be able to recruit coactivator CBP [66]. Thus,
whether p65 could obstruct MafK-mediated recruitment of CBP
to ARE was examined. DNA affinity-pull down experiment was
Fig. 4. p65 deprives CBP from Nrf2. (A) Effects of E1A, the CBP inhibitory protein, on p65- and Nrf2-mediated transcription. Either ARE-Luc and Nrf2 or NF-κB-
Luc and p65 were cotransfected together with or without indicated amounts of E1A expression vector into HepG2 cells for 30 h, then the normalized luciferase
activities were determined. (B) Competition between p65 and Nrf2(TAD) for binding to CBP. HEK293 cells were transiently transfected with indicated plasmids.
MG132 (10 μM) was added to the medium during the last 4-h cell culture to prevent proteasomal degradation of transfected Gal4-Nrf2(TAD). Endogenous CBP was
immunoprecipitated from the lysates with anti-CBP antibody, and Gal4-Nrf2(TAD), Flag-p65, and CBP in the immunoprecipitates were probed by anti-Gal4, anti-Flag
and anti-CBP antibodies, respectively. The expression levels of Gal4-Nrf2(TAD), Flag-p65 and CBP in cell lysates were analyzed by immunoblotting. (C) Inhibitory
effect of p65 and E1A on the Nrf2(TAD)-mediated Gal4-based transcription of reporter gene. HepG2 cells were transfected with (UAS)5-TATA-Luc reporter plasmid
and indicated expression vectors for 30 h, and then the normalized luciferase activities were determined. (D) Competition of p65 with Nrf2 for binding to CBP(116–
738). Nuclear extracts from HEK293 cells transfected with indicated plasmids were incubated with GST-bound or GST-CBP(116–738)-bound glutathione beads at
4 °C for 4 h. The associated Nrf2 and p65 in the precipitates were analyzed by immunoblotting with anti-Flag and anti-HA antibody respectively. (E) Effect of the
PKAc on the p65-exerted repression of the Nrf2-mediated transcription of HO-1(ARE)-driven reporter. HepG2 cells were cotransfected with ARE-Luc reporter
plasmid and various combination of the expression vectors (800 ng Nrf2, 80 ng p65, and 80 ng PKAc (wild-type or K72H)) for 30 h, and then the normalized luciferase
activities were determined. (F) Differential effects of p65 and its phosphorylation-deficient mutant p65(S276A) on the Nrf2(TAD)-mediated Gal4-based transcription
of reporter. HepG2 cells were cotransfected with (UAS)5-TATA-Luc reporter plasmid and various combination of the expression vectors (80 ng Gal4-Nrf2(TAD),
80 ng p65 (wild-type or S276A), and 800 ng CBP) for 30 h, and then the normalized luciferase activities were determined.
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nuclear extracts from the HA-CBP-transfected HEK293 cells.
As Fig. 5A shows, HA-CBP was obviously attached to the ARE
in the presence of both Nrf2 and MafK proteins, and the
cotransfected p65 did not interfere with the association of CBP
to ARE. Then, a ChIP assay was conducted in the HEK293 cells
transfected with (UAS)5-TATA-Luc and Gal4 or Gal4-MafK to
see if p65 could interrupt the recruitment of CBP to the DNA-
associated MafK. It was found that the endogenous CBP
selectively bound to the reporter promoter-associated Gal4-
MafK, but not to Gal4 alone. The MafK-CBP interaction was
unaffected by the cotransfection of p65 (Fig. 5B). Thisexperiment indicates that p65 is unable to interrupt the asso-
ciation of CBP with MafK, the protein bound to the CH3
domain in CBP [66], despite the fact that p65 effectively
deprives CBP from Nrf2.
3.4. p65 promotes recruitment of HDAC activity to ARE
Since above-described experiments clearly indicate that the
sequestration of CBP is a vital mechanism in the p65-excerted
repression of Nrf2, it may be expected that p65(S276A), the
CBP-binding-defective p65 mutant [65], would have no effect
on the ARE-mediated gene expression. To verify it, the effect of
Fig. 5. Association of CBP with MafK and ARE is unaffected by p65. (A) DNA-
pull down assay of association of CBP with ARE. After HEK293 cells were
transiently transfected with indicated combinations of HA-CBP, Nrf2/MafK and
p65 expression vectors for 40 h, the nuclear extracts were incubated with biotin-
labeled ARE probe. The CBP proteins coupled to ARE and existing in nuclear
extracts were determined respectively by immunoblotting with anti-HA
antibody. (B) ChIP assay of the endogenous CBP recruited to Gal4-MafK in
the HEK293 cells transfected with (UAS)5-TATA-luc reporter and a combina-
tion of p65, Gal4-MafK and Gal4.
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cells. It was surprisingly found that the p65(S276A) still
inhibited the ARE-driven transcription, though it was less
effective than the wild-type p65 (Fig. 6A). This suggests that
there might be any other mechanism involved in the inhibition
of ARE by p65. Since it was reported that p65 negatively
regulate some transcription factor-mediated gene expression by
facilitating the recruitment of the corepressors HDACs [5–8],
possible involvement of HDACs in p65-mediated ARE
inhibition was investigated. First of all, we examined if
trichostatin A (TSA), a HDAC inhibitor, could reverse the
effect of p65 on the ARE-mediated gene expression. As shown
in Fig. 6A, treatment of the transfected HepG2 cells with TSA
moderately reduced the wild type p65-mediated ARE inhibition
but completely eliminate the p65(S276A)-mediated ARE in-
hibition. Therefore, it suggests that the HDACs might be
involved in the p65-mediated repression of ARE. Since both
Nrf2 and its dimerization partner MafK are ARE-associated
proteins, it was then examined if Nrf2 and MafK could serve as
adapter to recruit HDACs. For this purpose, HDAC activity was
determined in the immunoprecipitate with either anti-Nrf2 or
anti-MafK antibody from the nuclear extract of HepG2. As
Fig. 6B shows, HDAC activity constitutively associated to
MafK rather than to Nrf2. To ascertain which subtype of
HDACs could be recruited to MafK, the effect of HDAC1, 2, 3,4, and 5 on the basal ARE activity was investigated. As shown
in Fig. 6C, only class I HDAC (1, 2, and 3) was found obviously
inhibit the ARE-dependent gene expression. CO-IP analysis
further demonstrated that Gal4-fused MafK, but not naked
Gal4, tightly bound to HDAC1 HDAC2, and HDAC3, though a
much weaker association of HDAC2 with Gal4 was detected
(Fig. 6D). No association of MafK with HDAC4 or HDAC5
was detected (data not shown). As HDACs can deacetylate a
bunch of transcription factors and coactivators, it was also
examined if HDAC could affect the acetylation status of MafK.
Similar to the previous report on MafG by other investigators
[60], the overexpression of CBP significantly induced acetyla-
tion of MafK in HEK293 cells (see lane 1 vs. lane 2 in Fig. 6E).
However, the acetylation could be effectively banned by simul-
taneous expression of HDAC1 or HDAC3 (see lane 3 and 4 in
Fig. 6E).
Due to its highest inhibitory effect on both ARE activation
and MafK acetylation (Fig. 6C and E), HDAC3 was chosen to
study the regulation of ARE activity by HDACs. First of all,
which domain of MafK interacts with HDAC3 was investi-
gated. Various Gal4-tagged MafK fragments were cotransfected
with Myc-tagged HDAC3 into HEK293 cells, and the MafK
fragment-associated HADC3 was then probed in the immuno-
precipitates with anti-Myc antibody from extract of the
transfected cells. As shown in Fig. 6F, the C-terminal Zip
domain of MafK (77–156 aa), that is known to mediate
dimerization with Nrf2, contains the HDAC3 docking site.
Therefore, a question was raised. How HDAC3 participates in
the p65-mediated repression of ARE? As the ARE-associated
MafK and CBP both have a potential to recruit HDAC3 [52], an
attempt was made to determine if p65 is capable of promoting
them to recruit HDAC3. CO-IP assay was performed in the
HEK293 cells cotransfected with various combinations of Gal4-
MafK, HA-CBP, Myc-HDAC3, and Myc-p65. As Fig. 7A
and B show, both MafK-associated and CBP-associated
HDAC3 markedly increased in the presence of the over-
expressed p65. It was interestingly found that Myc-p65 and
Myc-HDAC3 coexist in the CBP-containing protein complex
(Fig. 7B). This observation and the previous reports that p65
can interact with either CBP [4] or with HDAC3 [67], suggest
that p65 might facilitate the recruitment of HDAC3 to CBP by
serving as a adapter. Meanwhile, the effect of the constitutively
activated Nrf2 mutant, Nrf2(E82G), on MafK-HDAC3 and
CBP-HDAC3 interactions was examined. The reason for
utilizing Nrf2(E82G) but not wild-type Nrf2 is because that
the mutant can escape from Keap1-mediated proteasomal deg-
radation in cytosolic retention, thus maximally increases the
intra-nuclear Nrf2. As Fig. 7A shows, Nrf2(E82G) completely
abrogated HDAC3-MafK interaction possibly due to competi-
tion with HDAC3 for binding to the same Zip region of MafK.
Similarly, it was also found that the HDAC3-CBP interaction
was substantially impaired by Nrf2(E82G) (Fig. 7B). Taken
together, these observations suggest that p65 and Nrf2 exert
contrary effects on the recruitment of HDAC3 to both MafK and
CBP.
To confirm if p65 can promote recruitment of HDAC3 to
endogenous ARE under chromosomal environment where the
Fig. 6. The MafK mediates recruitment of HDAC to ARE. (A) Effects of TSA on p65- or its mutant p65(S276A)-exerted repression of the HO-1(ARE)-driven
transcription of luciferase. HepG2 cells were cotransfected with ARE-Luc reporter plasmid, and the indicated expression vectors for 18 h, followed by treatment with
TSA (300 nM) for 12 h, and then the normalized luciferase activities were determined. (B) Determination of Nrf2 or MafK-associated HDAC activity. The nuclear
extracts of HepG2 cells were immunoprecipitated with anti-Nrf2 and anti-MafK antibody respectively. The immunoprecipitates were subjected to HDAC activity
assay. The immunoprecipitation analysis with IgG and anti-HDAC1 antibody was used as the negative and positive controls respectively. (C) The effects of various
subtype of HDACs on basal ARE activity. HepG2 cells were cotransfected with HO-1(ARE)-Luc reporter plasmid, and the indicated expression vector for 30 h, and
then the normalized luciferase activities were determined. (D) The MafK-associated HDAC1, 2 and 3 in HEK293 cells transfected transiently with Gal4-MafK or Gal4
expression vector and indicated expression vectors for Myc-HDAC1, HDAC2 and HDAC3 respectively. The HDACs in the immunoprecipitates with anti-Gal4
antibody were probed with anti-Myc antibody (upper blots). The contents of HDAC1, 2 and 3 in cell lysates were determined by immunoblotting respectively (lower
blots). (E) Effect of the HDAC1 and 3 on the CBP-mediated MafK acetylation in HEK293 cells. The cells were transfected with various combination of Gal4-MafK,
CBP, HDAC1 and HDAC3. The lysates were immunoprecipitated with anti-MafK antibody and then the immunoprecipitates were subjected to immunoblotting with
anti-acetylated lysine antibody (αAC-K). The expression levels of MafK, HDAC1 and HDAC3 in cell lysates were immunoblotted with anti-Gal4 and anti-Myc
antibody respectively (lower panels). (F) Identification of the MafK domain that may interact with HDAC3. The Gal4-tagged full-length MafK or its domain-truncated
mutants, FL, N1, C1, C2 and C3 (see the left panel), were cotransfected with Myc-HDAC3 into HEK293 cells respectively. Associated HDAC3 was probed with anti-
Myc antibody in the immunoprecipitates of the lysates with anti-Gal4 antibody from the transfected cells (top blot on the right panel). The expression level of various
Gal4-tagged full-length or truncated MafKs and HDAC3 in the transfected cells was also determined (two lower blots on the right panel).
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existence of HDAC3 and acetylated H4 histone within the
endogenous ARE-enriched HO-1 E1 enhancer was examined
by ChIP analysis in the L929 cells transfected with either empty
or p65 expression vectors under Cd2+-stimulation. As shown in
Fig. 7C, a rather low level of HDAC3 was found to associate
with endogenous HO-1 E1 enhancer, while the local histone H4was highly acetylated in control cells (lane 1). In contrast, the
HO-1 E1 enhancer-associated HDAC3 was substantially
enhanced and the histone H4 was much less acetylated in the
p65-overexpressing cells (lane 2). However, the E1 enhancer-
associated MafK was kept constant regardless of the presence of
the overexpressed p65. Similar results were also obtained in a
ChIP experiment with the HEK293 cells transfected transiently
Fig. 7. p65 facilitates association of HDAC3 with either MafK or CBP and
promotes recruitment of HDAC3 to ARE. (A) The effects of p65 and Nrf2 on
HDAC3-MafK association in the HEK293 cells where Myc-HDAC3 and Gal4-
MafK were transfected with or without Myc-p65 or Nrf2(E82G) for 48 h. The
MafK-associated HDAC3 was probed by anti-Myc antibody in the immuno-
precipitates with anti-Gal4 antibody (the upper blot). The overexpressed
HDAC3 and p65 in the transfected cells were probed with anti-Myc antibody
(the lower blots). (B) The effects of p65 and Nrf2 on the HDAC3-CBP
association in the HEK293 cells where Myc-HDAC3 and HA-CBP were
transfected with or without either Myc-p65 or Nrf2(E82G) for 48 h. The CBP-
associated HDAC3 was probed by anti-Myc antibody in the immunoprecipitate
with anti-HA antibody from the lysates of the transfected cells (the upper blot).
The overexpressed HDAC3 and p65 in the transfected cells were probed with
anti-Myc antibody (the lower blots). (C) Enhanced association of HDAC3 to
HO-1 E1 enhancer by overexpression of p65. The stable Mock- or p65-
transfected L929 cells were stimulated with cadmium chloride for 2 h, then the
HO-1 E1 enhancer-associated MafK, HDAC3, and acetylated histone H4 were
analyzed by ChIP assay using anti-MafK, anti-HDAC3 and anti-acetylated
histone 4 antibodies respectively. The ChIP assay with normal IgG was
performed to show the specificity of interaction of the indicated proteins with the
target region.
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(data not shown). Thus, it was proved that p65 did promote the
recruitment of HADC3 to ARE at chromosomal level. The
recruitment would reasonably lead to repression of the ARE-
dependent gene expression. The ChIP results are consistent with
previously observed repression of the Cd2+-induced expression
of HO-1 in the p65-overexpressing cells (see Fig. 2A).3.5. Knockdown of the endogenous p65 led to more association
of CBP to Nrf2 and less recruitment of HDAC to MafK in
PMA-stimulated HepG2 cells
Previous results indicate that both the deprivation of CBP
from Nrf2 and the enhanced recruitment of HDAC3 to MafK
account for the p65-mediated silence of ARE. To ascertain the
existence of such mechanisms in a physiological setting where
both NF-κB and Nrf2 pathways are activated, it was
investigated how depletion of the endogenous p65 by p65
siRNA affects the CBP-Nrf2 or HDAC3-MafK interaction in
the HepG2 cells which were stimulated with PMA. CO-IP was
performed to examine if depletion of p65 would modulate level
of the endogenous Nrf2-associated CBP and the level of the
endogenous MafK-associated HADC3. As Fig. 8B shows, CBP
was co-immunoprecipitated with Nrf2, and PMA-stimulation
caused more co-immunoprecipitation of CBP (lanes 2–5). 70%
depletion of the endogenous p65 markedly increased the Nrf2-
associated CBP (lane 2 vs. lane 3), indicating that less p65
results in less deprivation of CBP from Nrf2. The increase
caused by depletion of p65 was even more significant under
PMA-stimulation, indicating that Nrf2 could capture more CBP
upon activation. As to the recruitment of HDAC3 to MafK, it
was found that endogenous HADC3 was surely immunopreci-
pitated with the MafK in the nuclear extracts of HepG2 cells
transfected with either p65 siRNA or the mock RNA (Fig. 8C).
Although PMA-stimulation slightly enhanced the recruitment
of HDAC3 to MafK (lane 3 vs. lane 2 in Fig. 8C), knockdown
of the endogenous p65 still led to less association of HADC3 to
MafK in the PMA-stimulated cells (lane 4 vs. lane3, Fig. 8C),
which indicates that less activation of p65 results in less
HADC3 recruited to MafK. In the above CO-IP experiments,
normal IgG was used as control, and no detectable CBP or
HADC3 was found in the immunoprecipitate with the IgG,
indicating that the CBP-Nrf2 and HADC3-MafK interaction are
specific. In addition, the MafK-associated HDAC activity was
analyzed. As shown in Fig. 8D, knockdown of the endogenous
p65 resulted in a clear reduction of MafK-associated HADC
activity in either unstimulated or the PMA-stimulated cells. It
was noticed that the PMA-stimulation caused significant
increase of the MafK-associated HDAC activity in the cells
transfection with mock RNA, but the increase was less sig-
nificant in the p65-knockdown cells These indicate that acti-
vated p65 is able to promote recruitment of HDAC3 to MafK,
and such a promotion was abrogated when the endogenous p65
was knocked down. Taken together, the opposing results
obtained with the p65-knockdown cells are in good agreement
with the previous observation that the overexpression of p65
deprived CBP from Nrf2 and promoted the recruitment of
HDAC3 to MafK.
4. Discussion
Aberrant NF-κB activity is a hallmark of cancer and chronic
inflammatory diseases. Constitutive activation of IKK and
consequent elevation of the nuclear level of p65 have been
reported in many inflammatory diseases and a variety of solid
Fig. 8. Effects on PMA-stimulated Nrf2-CBP and MafK-HDAC interactions in HepG2 cells by knockdown of endogenous p65. (A) Expression of p65 in HepG2 cells
transfected with various amounts of p65 siRNA for 72 h. Nonspecific double-stranded RNA (Mock) was used as a control, and expression of actin was used as
indication of equal loading of samples. (B) The Nrf2-associated CBP in the p65-knockdown cells or control cells stimulated with or without PMA (upper blot). About
6×107 cells were transfected with 200 nM of p65 siRNA or mock RNA for 72 h, and then stimulated with or without 100 nM PMA for 1 h. The Nrf2-associated CBP
was probed by anti-CBP antibody in the immunoprecipitate with anti-Nrf2 antibody or normal IgG in lysates of the cells. Contents of the endogenous CBP and Nrf2
were analyzed by immunoblotting with anti-CBP and anti-Nrf2 antibodies in the lysates (the middle and bottom blots). (C) The MafK-associated HDAC3 in the p65-
knockdown cells or control cells stimulated with or without PMA (upper blot). The MafK-associated HDAC3 was probed by anti-HDAC3 antibody in the
immunoprecipitate with anti-MafK antibody or normal IgG in the nuclear extracts of the cells transfected with p65 siRNA or mock RNA for 72 h. Contents of the
endogenous HDAC3 and MafK were analyzed by immunoblotting with anti-HDAC3 and anti-MafK antibodies in the cell lysates as controls (the middle and bottom
blots). (D) Relative activities of the MafK-associated HDAC determined in the immunoprecipitates with anti-MafK antibody or normal IgG in the nuclear extracts of
the cells transfected with p65 siRNA or mock RNA for 72 h and then stimulated with or without 100 nM PMA.
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NF-κB p65 subunit antagonized the anti-inflammatory and anti-
carcinogenetic Nrf2-ARE pathway through deprivation of CBP
from Nrf2 and promotion of the recruitment of HDAC3 to ARE.
As regards the former mechanism, we found that p65 selectively
deprived CBP from Nrf2 but not from its DNA-binding partner
MafK (Figs. 4 and 5). CBP is a well-established coactivator of
Nrf2 and is required for the transcriptional activity of Nrf2
[4,44]. Since this study showed that E1A, the CBP inhibitory
protein, almost completely abolished Nrf2-mediated ARE
activation (see Fig. S1 in supplementary data), CBP may be
considered as the dominant coactivator of Nrf2, and other
coactivators of Nrf2, such as recently identified P160/SRC3
[68] and MOZ [69], may function more or less in a CBP-
dependent way. Thus, It was suggested that the deprivation of
CBP from Nrf2 would substantially impair transcriptional
activity of Nrf2. With regard to the latter mechanism, it was
found that p65 enhanced the MafK-associated HDAC activity
(Figs. 7A, 8C and D) and facilitated the recruitment of
endogenous HDAC3 to the inherent AREs-enriched HO-1 E1
enhancer (Fig. 7C). Through this mechanism, recruited HDAC3
deacetylates CBP and abolishes its coactivator activity (see Fig.
S2 in supplementary data). The two discovered mechanisms are
expected to efficiently repress the ARE-dependent gene
transcription. On one hand, the transcriptional activity of Nrf2
is abrogated as a result of CBP sequestration. On the other hand,
the recruited HDAC abolish the coactivator activity of CBP bydeacetylation [52]. Since optimal co-transcriptional activity of
MafG was reported to require the CBP-mediated acetylation
[66], the deacetylation of MafK by HDAC3 may be also partly
responsible for the repression of ARE. Finally, the recruitment
of HDAC activity to ARE may help to maintain local chromo-
some in a condensed “histone hypoacetylation” state (Fig. 7C),
and hence impede local gene transcription [49].
In this investigation, the suppression of the Cd2+-induced
HO-1 gene expression by overexpression of p65 (see Fig. 2A)
was only presented as an example for demonstrating the p65-
exerted repression of ARE-dependent gene expression. Since
the p65-overexpressing cell system is reminiscent of various
inflammatory and tumor-associated tissues, in which p65 is
constitutively activated in nucleus, this finding may help us to
elucidate why oxidative stresses and toxic insults often occur in
those pathological loci. Actually, it would be the most ideal if
the repression of the ARE-dependent gene expression by
activated p65 could be observed in the presence of physiolo-
gical agonists of NF-κB. Unfortunately, such an experimental
condition seems difficult to meet, because many physiological
or pathological stimuli often activate both NF-κB and Nrf2-
ARE signaling [28–35]. For example, LPS, an inflammation-
related stimulus, activates either Nrf2 or NF-κB in human
monocytes [29,31], and flow shear stress, a physiological
vascular stimulus, also activates both Nrf2 and NF-κB in human
endothelial cells [30,35]. The simultaneously activated Nrf2
may enshroud the inhibitory effect of activated p65 on the ARE-
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NF-κB and Nrf2, as an example, an unchanged expression
rather than an “expected” repression of the Nrf2-target genes
was observed in PMA-stimulated HepG2 cells (data not
shown). Furthermore, the difficulty in demonstrating the
repression of the Nrf2 target genes by physiologically activated
p65 in a straightforward way may be due to the other fact that
some Nrf2 target genes (such as NQO1) also contain potential
NF-κB binding site in their promoters [70]. Thus, the repressive
effect of p65 on the Nrf2-mediated ARE-driven transcription
may be neutralized by the NF-κB-mediated transactivation of
the promoter in those genes. The coexistence of different cis-
elements on a promoter may also explain why siRNA against
p65 could not markedly upregulate HO-1 expression (data not
shown). Besides that, NF-κB and Nrf2 may cooperate with each
other in activating gene transcription in some specific cases. For
example, NF-κB and Nrf2 coordinately mediate transcription of
Galphai2 gene through simultaneously binding to the adjacent
cis-elements in the gene promoter [71], and Nrf2 regulates rat
glutamate–cysteine ligase catalytic subunit transcription indir-
ectly via NF-κB [72]. Hence, the integrated effect of Nrf2 and
p65 on the final output of the ARE-containing gene expression
may be stimulus- and/or promoter-dependent. Under physiolo-
gical conditions, the interference of p65 with Nrf2 transactiva-
tion may serve as a negative regulatory mechanism for fine
tuning of Nrf2-ARE signaling. If it is true, the antioxidant
activity of many natural phytochemicals might be attributed not
only to their direct stimulatory effect on Nrf2 signaling but also
to their ability in preventing p65-mediated repression of ARE
transactivity. However, it should be particularly pointed out that
the Nrf2-mediated ARE-driven gene expression would be
blocked to some extend by increased nuclear p65 in various
inflammatory and cancer tissues where p65 is constitutively
activated. Such a blockade may result in a deficiency of cellular
antioxidant potential and a subsequent increase of oxidative
stress. In turn, the increased oxidative stress may further
activate NF-κB [73]. Such a positive feedback mechanism may
aggravate the pathological processes of those diseases.
So far, p65 has been reported to repress transcription of some
non-NF-κB target genes by either competing for a limited
number of nuclear coactivators [11] or serving as a bridge to
connect corepressor to target TFs [7]. The present study may
show, for the first time, which the two mechanisms are actually
coordinated as a concerted process. The p65-mediated ARE
inhibition may begin with deprivation of CBP from Nrf2 (TAD)
(Fig. 4). This initial step might subsequently result in three
potential outcomes. (1) Deprivation of CBP from Nrf2 would
lead to a substantial decrease in Nrf2 transitivity (Fig. 4D). (2)
Since Nrf2-CBP interaction tends to prevent recruitment of
HDAC to CBP (Fig. 7B), disruption of the Nrf2-CBP interaction
may restore the ability of CBP to recruit HDAC and therefore
link the corepressor to ARE. (3) Deprivation of CBP from Nrf2
but not MafK by p65 may lead to a destabilization of the Nrf2-
MafK heterodimer. As a consequence, Nrf2 may lose its
inhibitory effect on MafK-HDAC3 interaction (Fig. 7A), and
the Zip region of MafK may be partially exposed to HDAC3.
Therefore, deprivation of CBP from Nrf2 by p65 may provide afavorable condition for the recruitment of HDAC to both CBP
andMafK, thereby resulting in a stable ARE repression. Besides
heterodimerization with Nrf2, MafK can also homodimerize at
the ARE site [22]. Promotion of HDAC3 recruitment to MafK
homodimer by p65 may provide an alternative explanation for
p65-exerted ARE repression without involvement of Nrf2.
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